{"id":50554,"date":"2025-09-10T13:26:12","date_gmt":"2025-09-10T12:26:12","guid":{"rendered":"https:\/\/www.ersnet.org\/?p=50554"},"modified":"2025-09-12T12:29:59","modified_gmt":"2025-09-12T11:29:59","slug":"biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms","status":"publish","type":"post","link":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/","title":{"rendered":"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

As negotiations on EU pharmaceutical legislation reforms continue, the Biomedical Alliance in Europe (BioMed Alliance) has released a statement calling for an agreement that improves access to medicines, responds to unmet medical needs and the needs of patient groups, whilst continuing to foster European innovation in biomedical research. \u00a0<\/p>\n","protected":false},"author":16603,"featured_media":50555,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_oasis_is_in_workflow":0,"_oasis_original":0,"_oasis_task_priority":"","footnotes":""},"categories":[103,22],"tags":[],"class_list":["post-50554","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-eu-affairs","category-news"],"acf":[],"yoast_head":"\nBiomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms - ERS - European Respiratory Society<\/title>\n<meta name=\"description\" content=\"As negotiations on EU pharmaceutical legislation reforms continue, the Biomedical Alliance in Europe (BioMed Alliance) has released a statement calling for an agreement that improves access to medicines, responds to unmet medical needs and the needs of patient groups, whilst continuing to foster European innovation in biomedical research. \u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms\" \/>\n<meta property=\"og:description\" content=\"As negotiations on EU pharmaceutical legislation reforms continue, the Biomedical Alliance in Europe (BioMed Alliance) has released a statement calling for an agreement that improves access to medicines, responds to unmet medical needs and the needs of patient groups, whilst continuing to foster European innovation in biomedical research. \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/\" \/>\n<meta property=\"og:site_name\" content=\"ERS - European Respiratory Society\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-10T12:26:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-12T11:29:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Joe Bamford\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms\" \/>\n<meta name=\"twitter:description\" content=\"As negotiations on EU pharmaceutical legislation reforms continue, the Biomedical Alliance in Europe (BioMed Alliance) has released a statement calling for an agreement that improves access to medicines, responds to unmet medical needs and the needs of patient groups, whilst continuing to foster European innovation in biomedical research. \u00a0\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Joe Bamford\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/\"},\"author\":{\"name\":\"Joe Bamford\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/person\/a9ae942c91091cc5a026256a7d88b70a\"},\"headline\":\"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms\",\"datePublished\":\"2025-09-10T12:26:12+00:00\",\"dateModified\":\"2025-09-12T11:29:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/\"},\"wordCount\":13,\"publisher\":{\"@id\":\"https:\/\/www.ersnet.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg\",\"articleSection\":[\"EU Affairs\",\"News\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/\",\"url\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/\",\"name\":\"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms - ERS - European Respiratory Society\",\"isPartOf\":{\"@id\":\"https:\/\/www.ersnet.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg\",\"datePublished\":\"2025-09-10T12:26:12+00:00\",\"dateModified\":\"2025-09-12T11:29:59+00:00\",\"description\":\"As negotiations on EU pharmaceutical legislation reforms continue, the Biomedical Alliance in Europe (BioMed Alliance) has released a statement calling for an agreement that improves access to medicines, responds to unmet medical needs and the needs of patient groups, whilst continuing to foster European innovation in biomedical research. \u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#primaryimage\",\"url\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg\",\"contentUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg\",\"width\":1600,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ersnet.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ersnet.org\/#website\",\"url\":\"https:\/\/www.ersnet.org\/\",\"name\":\"ERS - European Respiratory Society\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ersnet.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ersnet.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ersnet.org\/#organization\",\"name\":\"European Respiratory Society - ERS\",\"url\":\"https:\/\/www.ersnet.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png\",\"contentUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png\",\"width\":871,\"height\":253,\"caption\":\"European Respiratory Society - ERS\"},\"image\":{\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/person\/a9ae942c91091cc5a026256a7d88b70a\",\"name\":\"Joe Bamford\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/113f9009971b9151e4ef1e4e75501423253b3d2f517ae0781d133c8b15ea99cf?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/113f9009971b9151e4ef1e4e75501423253b3d2f517ae0781d133c8b15ea99cf?s=96&d=mm&r=g\",\"caption\":\"Joe Bamford\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms - ERS - European Respiratory Society","description":"As negotiations on EU pharmaceutical legislation reforms continue, the Biomedical Alliance in Europe (BioMed Alliance) has released a statement calling for an agreement that improves access to medicines, responds to unmet medical needs and the needs of patient groups, whilst continuing to foster European innovation in biomedical research. \u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/","og_locale":"en_GB","og_type":"article","og_title":"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms","og_description":"As negotiations on EU pharmaceutical legislation reforms continue, the Biomedical Alliance in Europe (BioMed Alliance) has released a statement calling for an agreement that improves access to medicines, responds to unmet medical needs and the needs of patient groups, whilst continuing to foster European innovation in biomedical research. \u00a0","og_url":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/","og_site_name":"ERS - European Respiratory Society","article_published_time":"2025-09-10T12:26:12+00:00","article_modified_time":"2025-09-12T11:29:59+00:00","og_image":[{"width":1600,"height":900,"url":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg","type":"image\/jpeg"}],"author":"Joe Bamford","twitter_card":"summary_large_image","twitter_title":"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms","twitter_description":"As negotiations on EU pharmaceutical legislation reforms continue, the Biomedical Alliance in Europe (BioMed Alliance) has released a statement calling for an agreement that improves access to medicines, responds to unmet medical needs and the needs of patient groups, whilst continuing to foster European innovation in biomedical research. \u00a0","twitter_image":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg","twitter_misc":{"Written by":"Joe Bamford","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#article","isPartOf":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/"},"author":{"name":"Joe Bamford","@id":"https:\/\/www.ersnet.org\/#\/schema\/person\/a9ae942c91091cc5a026256a7d88b70a"},"headline":"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms","datePublished":"2025-09-10T12:26:12+00:00","dateModified":"2025-09-12T11:29:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/"},"wordCount":13,"publisher":{"@id":"https:\/\/www.ersnet.org\/#organization"},"image":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg","articleSection":["EU Affairs","News"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/","url":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/","name":"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms - ERS - European Respiratory Society","isPartOf":{"@id":"https:\/\/www.ersnet.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#primaryimage"},"image":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg","datePublished":"2025-09-10T12:26:12+00:00","dateModified":"2025-09-12T11:29:59+00:00","description":"As negotiations on EU pharmaceutical legislation reforms continue, the Biomedical Alliance in Europe (BioMed Alliance) has released a statement calling for an agreement that improves access to medicines, responds to unmet medical needs and the needs of patient groups, whilst continuing to foster European innovation in biomedical research. \u00a0","breadcrumb":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#primaryimage","url":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg","contentUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2025\/09\/Biomed-alliance-web-page.jpg","width":1600,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/biomedical-alliance-statement-highlights-key-issues-in-eu-pharmaceutical-legislation-reforms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ersnet.org\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.ersnet.org\/news-and-features\/news\/"},{"@type":"ListItem","position":3,"name":"Biomedical Alliance statement highlights key issues in EU pharmaceutical legislation reforms"}]},{"@type":"WebSite","@id":"https:\/\/www.ersnet.org\/#website","url":"https:\/\/www.ersnet.org\/","name":"ERS - European Respiratory Society","description":"","publisher":{"@id":"https:\/\/www.ersnet.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ersnet.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.ersnet.org\/#organization","name":"European Respiratory Society - ERS","url":"https:\/\/www.ersnet.org\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png","contentUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png","width":871,"height":253,"caption":"European Respiratory Society - ERS"},"image":{"@id":"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.ersnet.org\/#\/schema\/person\/a9ae942c91091cc5a026256a7d88b70a","name":"Joe Bamford","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.ersnet.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/113f9009971b9151e4ef1e4e75501423253b3d2f517ae0781d133c8b15ea99cf?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/113f9009971b9151e4ef1e4e75501423253b3d2f517ae0781d133c8b15ea99cf?s=96&d=mm&r=g","caption":"Joe Bamford"}}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts\/50554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/users\/16603"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/comments?post=50554"}],"version-history":[{"count":2,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts\/50554\/revisions"}],"predecessor-version":[{"id":50620,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts\/50554\/revisions\/50620"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/media\/50555"}],"wp:attachment":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/media?parent=50554"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/categories?post=50554"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/tags?post=50554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}